TRPM1
protein-codingtransient receptor potential cation channel subfamily M member 1, the group of MicroRNA protein coding host genes|Transient receptor potential cation channels
Gene summary
This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
- MLSN1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~160.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013183
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013183
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0800402
Submitter: ClinGen
*TRPM1* was first reported in relation to autosomal recessive cases of congenital stationary night blindness type 1C by three groups in 2009 (PMIDs: 19878917, 19896109, 19896113). The hallmark CSNB phenotype is night blindness from birth or early childhood with a severely reduced or completely absent scotopic b-wave in an ERG, but normal or mildly affected a-wave. Patients also commonly present with myopia, nystagmus and/or strabismus. Because of the broad spectrum of potential phenotypes, these cases with causal variants in *TRPM1* have been curated under the inclusive disease name *TRPM1*-related retinopathy (MONDO:0800402). Twelve variants (four nonsense, three missense, two frameshift, and three intronic) that have been reported in eight probands in five publications (PMIDs: 35633130, 19896113, 20300565, 19896109, 19878917) are included in this curation. The mechanism of pathogenicity appears to be biallelic loss-of-function. This gene-disease association is also supported by experimental evidence that *TRPM1* exhibits its highest expression levels in retina tissue (PMID: 19878917). Additionally, expression of TRPM1 in the retina of horses with a CSNB phenotype is 0.05% of the level found in horses with normal vision (PMID: 18660533). Immunolocalization shows that TRPM1 is localized to ON bipolar cell dendrites in the outer plexiform layer (OPL) of the retina (PMID: 19896109). The ERG b-wave is absent (a defining phenotype of CSNB) in a *Trpm1 (-/-)* knockout mouse (PMID: 20300565). These ERG results have been replicated in another *Trpm1* null mutant mouse experiment (PMID: 19861548). Furthermore, this group has also found that TRPM1 immuno-staining is absent in the OPL layer of retinal cells in *Trpm1(−/−)* mice. They go on to show that OKR response is reduced in knockout mice. Finally, these authors show that cell response is absent (in rod cells) or highly altered (in cone cells) in *Trpm1 (-/-)* mice (PMID: 19861548). In summary, *TRPM1* is definitively associated with autosomal recessive inheritance of *TRPM1*-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification according to the ClinGen template. This classification was approved by the ClinGen Retina GCEP on October 6, 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0013183
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Dermatologic findings (eg, dry skin; a condition resembling epidermolysis bullosa simplex) have been described, but it is not clear if these are part of the core phenotype
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRPM1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001252024.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 7 | 316 | 3 | 328 | |
| missense | 1 | 34 | 634 | 64 | 2 | 735 |
| nonsense | 18 | 17 | 2 | 3 | 40 | |
| start loss | 0 | |||||
| frameshift | 26 | 16 | 8 | 6 | 56 | |
| splice donor/acceptor (+/-2bp) | 5 | 30 | 35 | |||
| Total | 50 | 99 | 651 | 389 | 5 | 1194 |
Highest pathogenic variant AF is 0.00030605064
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001238953.1 | 27 | MANE Select | |
| Ensembl | ENSP00000256552.7 | 27 | MANE Select | |
| RefSeq | NP_001238949.1 | 27 | Standard | |
| RefSeq | NP_001238959.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Stimuli-sensing channels
- Ion channel transport
- Transport of small molecules
- TRP channels
Biological Process
- G protein-coupled glutamate receptor signaling pathway
- visual perception
- retinal rod cell development
- protein tetramerization
- calcium ion transport into cytosol
Molecular Function
- calcium channel activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- new growing cell tip
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000542188
- Coding exons
- 27
- Length
- 160213
- Individuals with no LoFs
- 109924
- Homozygous LoFs
- 681
- Heterozygous LoFs
- 14678
- Defined
- 125283
- p
- 0.0633
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.131 | 914 | 903 | 1.01 | 0.0000561 | 10813 |
| Missense (PolyPhen) | 347 | 355.74 | 0.97543 | 4200 | ||
| Synonymous | -0.981 | 380 | 356 | 1.07 | 0.0000239 | 3120 |
| Loss of Function | 1.03 | 70 | 80.0 | 0.875 | 0.00000457 | 942 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.082 | 0.080 | notable |
| Latino/Admixed American | 0.035 | 0.035 | notable |
| Ashkenazi Jewish | 0.070 | 0.069 | notable |
| East Asian | 0.011 | 0.011 | notable |
| Finnish | 0.069 | 0.069 | notable |
| European (Non-Finnish) | 0.059 | 0.059 | notable |
| South Asian | 0.13 | 0.13 | notable |
| Other | 0.066 | 0.066 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cation channel essential for the depolarizing photoresponse of retinal ON bipolar cells. It is part of the GRM6 signaling cascade. May play a role in metastasis suppression (By similarity). May act as a spontaneously active, calcium-permeable plasma membrane channel. {ECO:0000250, ECO:0000269|PubMed:11535825, ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109}.;
- Disease
- DISEASE: Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]: A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. {ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109, ECO:0000269|PubMed:19896113}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- LoFtool
- 0.884
- RVIS EVS
- 1.75
- RVIS percentile EVS
- 96.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.156
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |